Kenzo Yamamura

781 total citations
24 papers, 625 citations indexed

About

Kenzo Yamamura is a scholar working on Pharmaceutical Science, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Kenzo Yamamura has authored 24 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmaceutical Science, 10 papers in Public Health, Environmental and Occupational Health and 5 papers in Molecular Biology. Recurrent topics in Kenzo Yamamura's work include Advanced Drug Delivery Systems (15 papers), Ocular Surface and Contact Lens (10 papers) and Advancements in Transdermal Drug Delivery (6 papers). Kenzo Yamamura is often cited by papers focused on Advanced Drug Delivery Systems (15 papers), Ocular Surface and Contact Lens (10 papers) and Advancements in Transdermal Drug Delivery (6 papers). Kenzo Yamamura collaborates with scholars based in Japan and United States. Kenzo Yamamura's co-authors include Junzo Nakamura, Koyo Nishida, Hitoshi Sasaki, Masataka Ichikawa, Takahiro Mukai, Mikiro Nakashima, Shigeru Kawakami, Toshiaki Nagano, Naveed Shams and Noriko Odani‐Kawabata and has published in prestigious journals such as Journal of Controlled Release, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Kenzo Yamamura

24 papers receiving 594 citations

Peers

Kenzo Yamamura
Ola Camber Sweden
Vincent H.L. Lee United States
Sriram Gunda United States
Sukhbir S. Chrai United States
Janet A. Anderson United States
Vincent H. L. Lee United States
Yumei Wu China
Kenzo Yamamura
Citations per year, relative to Kenzo Yamamura Kenzo Yamamura (= 1×) peers Lotta Salminen

Countries citing papers authored by Kenzo Yamamura

Since Specialization
Citations

This map shows the geographic impact of Kenzo Yamamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenzo Yamamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenzo Yamamura more than expected).

Fields of papers citing papers by Kenzo Yamamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenzo Yamamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenzo Yamamura. The network helps show where Kenzo Yamamura may publish in the future.

Co-authorship network of co-authors of Kenzo Yamamura

This figure shows the co-authorship network connecting the top 25 collaborators of Kenzo Yamamura. A scholar is included among the top collaborators of Kenzo Yamamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenzo Yamamura. Kenzo Yamamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aihara, Makoto, Fenghe Lu, Yuki Tanaka, et al.. (2019). Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study). Journal of Ocular Pharmacology and Therapeutics. 35(10). 542–550. 22 indexed citations
2.
Taniguchi, Takazumi, Kenzo Yamamura, Ryo Iwamura, et al.. (2018). Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent. Investigative Ophthalmology & Visual Science. 59(1). 145–145. 71 indexed citations
3.
Aihara, Makoto, Fenghe Lu, Yuki Tanaka, et al.. (2017). Pharmacokinetics, Safety and IOP Lowering Profiles of omidenepag isopropyl, a Selective EP2 Agonist in Healthy Japanese and Caucasian Volunteers (Phase I Study). Investigative Ophthalmology & Visual Science. 58(8). 2104–2104. 5 indexed citations
6.
Kawakami, Shigeru, Koyo Nishida, Takahiro Mukai, et al.. (2001). Controlled release and ocular absorption of tilisolol utilizing ophthalmic insert-incorporated lipophilic prodrugs. Journal of Controlled Release. 76(3). 255–263. 24 indexed citations
7.
Kawakami, Shigeru, Koyo Nishida, Takahiro Mukai, et al.. (2001). Ocular absorption behavior of palmitoyl tilisolol, an amphiphilic prodrug of tilisolol, for ocular drug delivery. Journal of Pharmaceutical Sciences. 90(12). 2113–2120. 8 indexed citations
8.
Sasaki, Hitoshi, Kenzo Yamamura, Takahiro Mukai, et al.. (2000). Pharmacokinetic Prediction of the Ocular Absorption of an Instilled Drug with Ophthalmic Viscous Vehicle.. Biological and Pharmaceutical Bulletin. 23(11). 1352–1356. 15 indexed citations
9.
Sasaki, Hitoshi, Kenzo Yamamura, Takahiro Mukai, et al.. (2000). Modification of Ocular Permeability of Peptide Drugs by Absorption Promoters.. Biological and Pharmaceutical Bulletin. 23(12). 1524–1527. 21 indexed citations
10.
Yamamura, Kenzo, et al.. (1999). Characterization of Ocular Pharmacokinetics of Beta-Blockers Using a Diffusion Model After Instillation. Pharmaceutical Research. 16(10). 1596–1601. 19 indexed citations
11.
Sasaki, Hitoshi, et al.. (1999). Characterization of Ocular Pharmacokinetics of Tilisolol after Instillation into Anesthetized Rabbits.. Biological and Pharmaceutical Bulletin. 22(11). 1253–1255. 3 indexed citations
12.
Sasaki, Hitoshi, Kenzo Yamamura, Takahiro Mukai, et al.. (1999). Enhancement of Ocular Drug Penetration. Critical Reviews in Therapeutic Drug Carrier Systems. 16(1). 62–62. 97 indexed citations
13.
Sasaki, Hitoshi, Kenzo Yamamura, Takahiro Mukai, et al.. (1997). In Vivo Ocular Pharmacokinetic Model for Designing Dosage Schedules and Formulations of Ophthalmic Drugs in Human. Nagasaki University's Academic Output SITE (Nagasaki University). 42(3). 45–50. 8 indexed citations
14.
Nakashima, M, Hidetada Sasaki, Akihiro Ohira, et al.. (1997). In-vivo Ocular Microdialysis to Monitor Ocularly Applied Cyclosporin in the Anterior Chamber of Rabbits. Pharmacy and Pharmacology Communications. 3(4). 179–182. 2 indexed citations
15.
Sasaki, Hitoshi, Masataka Ichikawa, Kenzo Yamamura, Koyo Nishida, & Junzo Nakamura. (1997). Ocular Membrane Permeability of Hydrophilic Drugs for Ocular Peptide Delivery. Journal of Pharmacy and Pharmacology. 49(2). 135–139. 18 indexed citations
16.
Sasaki, Hitoshi, Masataka Ichikawa, Shigeru Kawakami, et al.. (1996). In Situ Ocular Absorption of Tilisolol Through Ocular Membranes in Albino Rabbits. Journal of Pharmaceutical Sciences. 85(9). 940–943. 21 indexed citations
17.
Sasaki, Hitoshi, Kenzo Yamamura, Koyo Nishida, Junzo Nakamura, & Masataka Ichikawa. (1996). Delivery of drugs to the eye by topical application. Progress in Retinal and Eye Research. 15(2). 583–620. 91 indexed citations
18.
Yamamura, Kenzo, et al.. (1995). Ocular Permeability of FITC-Dextran with Absorption Promoter for Ocular Delivery of Peptide Drug. Journal of drug targeting. 3(2). 129–135. 28 indexed citations
19.
Sasaki, Hitoshi, Toshiaki Nagano, Kenzo Yamamura, Koyo Nishida, & Junzo Nakamura. (1995). Ophthalmic Preservatives as Absorption Promoters for Ocular Drug Delivery. Journal of Pharmacy and Pharmacology. 47(9). 703–707. 38 indexed citations
20.
Sasaki, Hitoshi, et al.. (1994). Effect of Preservatives on Systemic Delivery of Insulin by Ocular Instillation in Rabbits. Journal of Pharmacy and Pharmacology. 46(11). 871–875. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026